<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JDR</journal-id>
<journal-id journal-id-type="hwp">spjdr</journal-id>
<journal-id journal-id-type="nlm-ta">J Dent Res</journal-id>
<journal-title>Journal of Dental Research</journal-title>
<issn pub-type="ppub">0022-0345</issn>
<issn pub-type="epub">1544-0591</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0022034511435329</article-id>
<article-id pub-id-type="publisher-id">10.1177_0022034511435329</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Reports</subject>
<subj-group subj-group-type="heading">
<subject>Biological</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Chlorhexidine Inhibits the Activity of Dental Cysteine Cathepsins</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Scaffa</surname><given-names>P.M.C.</given-names></name>
<xref ref-type="aff" rid="aff1-0022034511435329">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Vidal</surname><given-names>C.M.P.</given-names></name>
<xref ref-type="aff" rid="aff1-0022034511435329">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Barros</surname><given-names>N.</given-names></name>
<xref ref-type="aff" rid="aff2-0022034511435329">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Gesteira</surname><given-names>T.F.</given-names></name>
<xref ref-type="aff" rid="aff3-0022034511435329">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Carmona</surname><given-names>A.K.</given-names></name>
<xref ref-type="aff" rid="aff2-0022034511435329">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Breschi</surname><given-names>L.</given-names></name>
<xref ref-type="aff" rid="aff4-0022034511435329">4</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Pashley</surname><given-names>D.H.</given-names></name>
<xref ref-type="aff" rid="aff5-0022034511435329">5</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Tjäderhane</surname><given-names>L.</given-names></name>
<xref ref-type="aff" rid="aff6-0022034511435329">6</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Tersariol</surname><given-names>I.L.S.</given-names></name>
<xref ref-type="aff" rid="aff3-0022034511435329">3</xref>
<xref ref-type="aff" rid="aff7-0022034511435329">7</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Nascimento</surname><given-names>F.D.</given-names></name>
<xref ref-type="aff" rid="aff8-0022034511435329">8</xref>
<xref ref-type="corresp" rid="corresp1-0022034511435329">*</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Carrilho</surname><given-names>M.R.</given-names></name>
<xref ref-type="aff" rid="aff8-0022034511435329">8</xref>
<xref ref-type="corresp" rid="corresp1-0022034511435329">*</xref>
</contrib>
</contrib-group>
<aff id="aff1-0022034511435329"><label>1</label>Department of Restorative Dentistry, Piracicaba Dental School, State University of Campinas, Piracicaba, Brazil</aff>
<aff id="aff2-0022034511435329"><label>2</label>Department of Biophysics, Federal University of São Paulo, São Paulo, Brazil</aff>
<aff id="aff3-0022034511435329"><label>3</label>Department of Biochemistry, Federal University of São Paulo, São Paulo, Brazil</aff>
<aff id="aff4-0022034511435329"><label>4</label>Department of Biomedicine, University of Trieste, and IGM-CNR and Unit of Bologna c/o IOR, Bologna, Italy</aff>
<aff id="aff5-0022034511435329"><label>5</label>Department of Oral Biology, College of Dental Medicine, Georgia Health Sciences University, Augusta, GA, USA</aff>
<aff id="aff6-0022034511435329"><label>6</label>Institute of Dentistry, University of Oulu and Oulu University Hospital, Oulu, Finland</aff>
<aff id="aff7-0022034511435329"><label>7</label>Centro Interdisciplinar de Investigação Bioquímica, University of Mogi das Cruzes, Mogi das Cruzes, Brazil</aff>
<aff id="aff8-0022034511435329"><label>8</label>Biomaterials Research Group, Bandeirante University of São Paulo, Rua Maria Cândida, 1813, 6 andar, São Paulo, 02071-013, Brazil</aff>
<author-notes>
<corresp id="corresp1-0022034511435329"><label>*</label><email>marcelacarrilho@gmail.com</email>, <email>fdnascimento@gmail.com</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>4</month>
<year>2012</year>
</pub-date>
<volume>91</volume>
<issue>4</issue>
<fpage>420</fpage>
<lpage>425</lpage>
<history>
<date date-type="received">
<day>11</day>
<month>10</month>
<year>2011</year>
</date>
<date date-type="rev-recd">
<day>16</day>
<month>12</month>
<year>2011</year>
</date>
<date date-type="accepted">
<day>16</day>
<month>12</month>
<year>2011</year>
</date>
</history>
<permissions>
<copyright-statement>© 2012 International &amp; American Associations for Dental Research</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">International &amp; American Associations for Dental Research</copyright-holder>
</permissions>
<abstract>
<p>The co-expression of MMPs and cysteine cathepsins in the human dentin-pulp complex indicates that both classes of enzymes can contribute to the endogenous proteolytic activity of dentin. Chlorhexidine (CHX) is an efficient inhibitor of MMP activity. This study investigated whether CHX could also inhibit cysteine cathepsins present in dentin. The inhibitory profile of CHX on the activity of dentin-extracted and recombinant cysteine cathepsins (B, K, and L) was monitored in fluorogenic substrates. The rate of substrate hydrolysis was spectrofluorimetrically measured, and inhibitory constants were calculated. Molecular docking was performed to predict the binding affinity between CHX and cysteine cathepsins. The results showed that CHX inhibited the proteolytic activity of dentin-extracted cysteine cathepsins in a dose-dependent manner. The proteolytic activity of human recombinant cathepsins was also inhibited by CHX. Molecular docking analysis suggested that CHX strongly interacts with the subsites S2 to S2′ of cysteine cathepsins B, K, and L in a very similar manner. Taken together, these results clearly showed that CHX is a potent inhibitor of the cysteine cathepsins-proteolytic enzymes present in the dentin-pulp complex.</p>
</abstract>
<kwd-group>
<kwd>cysteine cathepsins</kwd>
<kwd>chlorhexidine</kwd>
<kwd>proteolytic activity</kwd>
<kwd>dentin</kwd>
<kwd>collagen</kwd>
<kwd>degradation</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0022034511435329" sec-type="intro">
<title>Introduction</title>
<p>Identification of matrix metalloproteases (MMPs) (<xref ref-type="bibr" rid="bibr21-0022034511435329">Mazzoni <italic>et al</italic>., 2007</xref>; <xref ref-type="bibr" rid="bibr29-0022034511435329">Sulkala <italic>et al</italic>., 2007</xref>) and determination of their activity in dentin matrix (<xref ref-type="bibr" rid="bibr26-0022034511435329">Pashley <italic>et al</italic>., 2004</xref>) support the notion that these proteases play a central role in the proteolytic degradation of poorly resin-infiltrated dentin matrices in adhesive restorations (<xref ref-type="bibr" rid="bibr27-0022034511435329">Pashley <italic>et al</italic>., 2011</xref>).</p>
<p>In addition to MMPs, lysosomal papain-like cysteine proteases from the cathepsin family have been shown to participate in various physiological and pathological conditions which result in the degradation of extracellular matrix components (<xref ref-type="bibr" rid="bibr33-0022034511435329">Turk <italic>et al</italic>., 1997</xref>; <xref ref-type="bibr" rid="bibr8-0022034511435329">Dickinson, 2002</xref>; <xref ref-type="bibr" rid="bibr18-0022034511435329">Li <italic>et al</italic>., 2004</xref>). Recently, the gene expression for different cysteine cathepsins was demonstrated in human pulp and odontoblasts, with the major presence of cathepsin B (<xref ref-type="bibr" rid="bibr30-0022034511435329">Tersariol <italic>et al</italic>., 2010</xref>). Moreover, cysteine cathepsin activities in dentin and their correlation with MMPs activities were also detected (<xref ref-type="bibr" rid="bibr30-0022034511435329">Tersariol <italic>et al</italic>., 2010</xref>). These findings strongly suggest that MMPs and cysteine cathepsins may be responsible for the endogenous proteolytic activity of dentin, contributing to collagen degradation, not only within hybrid layers (<xref ref-type="bibr" rid="bibr14-0022034511435329">Hebling <italic>et al</italic>., 2005</xref>; <xref ref-type="bibr" rid="bibr5-0022034511435329">Carrilho <italic>et al</italic>., 2007</xref>) but also in caries lesions (<xref ref-type="bibr" rid="bibr32-0022034511435329">Tjäderhane <italic>et al</italic>., 1998</xref>; <xref ref-type="bibr" rid="bibr24-0022034511435329">Nascimento <italic>et al</italic>., 2011</xref>).</p>
<p>The success of chlorhexidine (CHX) in increasing the durability of resin-dentin bonds has been mainly credited to its ability to strongly inhibit the proteolytic activity of MMP-2, -8, and -9 (<xref ref-type="bibr" rid="bibr9-0022034511435329">Gendron <italic>et al</italic>., 1999</xref>), 3 of the MMPs identified in human dentin (<xref ref-type="bibr" rid="bibr20-0022034511435329">Martin-de Las Heras <italic>et al</italic>., 2000</xref>; <xref ref-type="bibr" rid="bibr21-0022034511435329">Mazzoni <italic>et al</italic>., 2007</xref>; <xref ref-type="bibr" rid="bibr29-0022034511435329">Sulkala <italic>et al</italic>., 2007</xref>). The use of specific MMP inhibitors, like Galardin, can reduce the host-derived proteolytic activity of dentin (<xref ref-type="bibr" rid="bibr4-0022034511435329">Breschi <italic>et al</italic>., 2010</xref>). However, since MMPs are not the only proteases present in dentin, a broad-spectrum inhibitor could be essential to inhibiting other dentinal proteolytic enzymes. Since CHX has other clinically advantageous features—such as antimicrobial function (<xref ref-type="bibr" rid="bibr16-0022034511435329">Lessa <italic>et al</italic>., 2010a</xref>), high substantivity to dentin matrix (<xref ref-type="bibr" rid="bibr6-0022034511435329">Carrilho <italic>et al</italic>., 2010</xref>; <xref ref-type="bibr" rid="bibr15-0022034511435329">Kim <italic>et al</italic>., 2010</xref>), and minor transdentinal cytotoxicity (<xref ref-type="bibr" rid="bibr17-0022034511435329">Lessa <italic>et al</italic>., 2010b</xref>)—it is important to determine whether CHX possesses non-specific inhibitory activity against dentinal cysteine cathepsins.</p>
<p>The objective of this study was to investigate the potential interaction between CHX and the cysteine cathepsins B, L, and K. The tested hypothesis was that chlorhexidine interacts with and inhibits cysteine cathepsins.</p>
</sec>
<sec id="section2-0022034511435329" sec-type="materials|methods">
<title>Materials &amp; Methods</title>
<p>Three experiments were performed: (1) monitoring of proteolytic activity of dentin extracts in the absence and presence of an aqueous solution of chlorhexidine digluconate (CHX), using a cysteine cathepsins-fluorogenic substrate, Z-FR-MCA (Carbobenzoxy- Phe-Arg-4-methylcoumarin-7-amide) and its specific inhibitor E-64; (2) monitoring the activity of recombinant human cathepsins B, L, and K in the presence/absence of CHX; and (3) estimation of the affinity between CHX and cathepsins by molecular docking.</p>
<p>Reagents were purchased from Sigma Chemical (St. Louis, MO, USA) unless otherwise specified.</p>
<sec id="section3-0022034511435329">
<title>Monitoring of the Proteolytic Activity in Dentin Extracts</title>
<p>Fifteen freshly extracted human molars obtained from young individuals (23-31 yrs) were used in this protocol, which was approved by the IRB Committee of Piracicaba School of Dentistry/UNICAMP. After complete removal of enamel and cementum, fragments of mid-coronal dentin from all teeth were obtained, pooled, dried with acetone for 5 min, and frozen at −80ºC for 24 hrs. Those fragments were further reduced in a ball-mill (MM401, Retsch, Newtown, PA, USA) at 30 Hz for 7 min. The resultant powder was sieved (#400 mesh), and a 1.2-g aliquot of dentin was used for enzyme extraction, according to a protocol described previously (<xref ref-type="bibr" rid="bibr20-0022034511435329">Martin-de Las Heras <italic>et al</italic>., 2000</xref>). Briefly, dentin powder was treated with 4 M guanidine-HCl (G1-extract), then demineralized with 0.5 M ethylenediaminetetraacetic acid (EDTA-extracts), and again treated with 4 M guanidine-HCl (G2-extract). The amount of protein in the G2-extract was determined by the Bio-Rad dye-binding assay (Bio-Rad Laboratories, Inc., Hercules, CA, USA), which is based on Bradford’s method (<xref ref-type="bibr" rid="bibr3-0022034511435329">Bradford, 1976</xref>).</p>
<p>Cysteine cathepsin activities in dentin G2-extracts were monitored with the fluorogenic substrate Z-FR-MCA in a Genius Tecanfluorometer (Mannedorf, Switzerland). Z-FR-MCA is a suitable substrate for cysteine cathepsins, due to its amino acid sequence, which covers S3, S2, S1, and S1′, the main substrate-binding sites in the papain-like cysteine proteases (<xref ref-type="bibr" rid="bibr1-0022034511435329">Barrett, 1980</xref>; <xref ref-type="bibr" rid="bibr23-0022034511435329">Nägler <italic>et al</italic>., 1997</xref>). Prior to the assay, 10-µL aliquots of dentin extracts were activated in 50 mM 2-(<italic>N</italic>-morpholino ethane) sulfonic acid buffer (pH 5.5) containing 1 mM dithiothreitol for 5 min at 37ºC. Excitation and emission wavelengths were set at 380 and 460 nm, respectively. The kinetics of 5 µM Z-FR-MCA hydrolysis was performed in the same activating buffer, in the absence or presence of CHX (final concentrations between 0 and 10 mM). Substrate hydrolysis was determined by measurement of the rate increase of fluorescence at 460 nm. The experiments were performed in quadruplicate. The selective substrate hydrolysis was checked with 5 µM E-64, a specific inhibitor of cysteine protease (<xref ref-type="bibr" rid="bibr8-0022034511435329">Dickinson, 2002</xref>). The enzyme activity was verified for linear variations in reaction time with an increasing volume of samples. The specific activities were calculated with reference to total protein.</p>
</sec>
<sec id="section4-0022034511435329">
<title>Monitoring of Activity of Recombinant Cathepsins B, L, and K</title>
<p>Recombinant cathepsins B, L (Calbiochem, San Diego, CA, USA), and K (expressed and purified in our lab) were used. The activity of these enzymes was also monitored with the Z-FR-MCA substrate in a Hitachi fluorometer (Scientific Instruments, Inc., Hialeah, FL, USA) with and without CHX at pH 5, as described above. Cathepsin B is the only member of the papain superfamily to exhibit both endo- and exopeptidase (carboxydipeptidylpeptidase) activity. At lower pH, as found in lysosomes (4.5-5.5), cathepsin B acts primarily as an exopeptidase (<xref ref-type="bibr" rid="bibr22-0022034511435329">Musil <italic>et al</italic>., 1991</xref>), while at higher pH (6.7-7.4), it exhibits an endopeptidase activity (<xref ref-type="bibr" rid="bibr23-0022034511435329">Nägler <italic>et al</italic>., 1997</xref>). Thus, for cathepsin B, the monitoring of substrate hydrolysis was also performed at pH 6.7.</p>
<p>The rate of substrate hydrolysis was continuously monitored by measurement of the rate of fluorescence increase at 460 nm as a function of time. The enzyme concentration for initial rate determinations was chosen so that &lt; 5% of the substrate was hydrolyzed. The data were analyzed and equations were fitted in GraFit (version 5.0; Erithacus Software Ltd., Horley, UK). The equation used to calculate the <italic>K</italic><sub>I</sub> values for CHX inhibition was <italic>K</italic><sub>I</sub> = <italic>K</italic><sub>Iapp</sub>/ (1 + [S]/<italic>K</italic><sub>M</sub>), where [S] = molar concentration of the substrate, <italic>K</italic><sub>M</sub> = Michaelis constant, and <italic>K</italic><sub>Iapp</sub> = apparent inhibition constant. <italic>K</italic><sub>Iapp</sub> was calculated according to the equation (V<sub>0</sub><italic>/</italic>V<sub>i</sub>) = 1 + [I]/<italic>K</italic><sub>Iapp</sub>, where V<sub>0</sub> = velocity of hydrolysis without the inhibitor, V<sub>i</sub> = velocity of hydrolysis in the presence of the inhibitor, and [I] = molar concentration of CHX. A plot of (V<sub>0</sub><italic>/</italic>V<sub>i</sub>) −1 <italic>vs</italic>. [I] yields a slope of 1/<italic>K</italic><sub>Iapp</sub> (<xref ref-type="bibr" rid="bibr19-0022034511435329">Machado <italic>et al</italic>., 2007</xref>).</p>
<p>Additionally, we measured binding of CHX by determining the change in intrinsic fluorescence of tryptophan residues in human recombinant cathepsin B. Intrinsic tryptophan fluorescence was monitored by measurement of the fluorescence emission (λ<sub>em</sub>) of 1 µM cathepsin B concentration at 300-450 nm (5-nm slit) after excitation at λ<sub>ex</sub> = 285 nm (5-nm slit) with a Hitachi spectrofluorometer. The interaction of CHX with recombinant cathepsin B was determined by measurement of the change in intrinsic fluorescence observed in the presence of 100 µM CHX in 50 mm MES, pH 5.5, 37°C. Signal from buffer alone was subtracted from the readings, to eliminate the background (<xref ref-type="bibr" rid="bibr10-0022034511435329">Gesteira <italic>et al</italic>., 2011</xref>).</p>
</sec>
<sec id="section5-0022034511435329">
<title>Molecular Docking Analysis of CHX and Cysteine Cathepsin Interactions</title>
<p>A mathematical modeling approach (<italic>i.e</italic>., molecular docking) was used to predict the binding affinity between CHX and cathepsins. Docking simulations were carried out with the Autodock 4.2 package (The Scripps Research Institute, La Jolla, CA, USA). CHX parameters were generated by a MMFF94s force field (<xref ref-type="bibr" rid="bibr13-0022034511435329">Halgren, 1999</xref>) as ionized forms. For consistency of partial charges with receptors, single-point calculations were performed with the General Atomic and Molecular Electronic Structure System (GAMESS) (<xref ref-type="bibr" rid="bibr11-0022034511435329">Gordon and Schmidt, 2005</xref>) to obtain the electrostatic potential with HF/6-31G* level of theory, with equivalent atoms given equal partial charges. CHX input was prepared in an Autotors module in Autodock 4.2. The structures of cathepsins K, B, and L were retrieved from the Protein Data Bank (<xref ref-type="bibr" rid="bibr31-0022034511435329">Thompson <italic>et al</italic>., 1997</xref>; <xref ref-type="bibr" rid="bibr2-0022034511435329">Berman <italic>et al</italic>., 2000</xref>; <xref ref-type="bibr" rid="bibr12-0022034511435329">Greenspan <italic>et al</italic>., 2001</xref>; <xref ref-type="bibr" rid="bibr7-0022034511435329">Chowdhury <italic>et al</italic>., 2002</xref>) and prepared as previously described (<xref ref-type="bibr" rid="bibr10-0022034511435329">Gesteira <italic>et al</italic>., 2011</xref>). The Autogrid settings were averaged around the catalytic triad, with grid spacing of 0.327 Å for grid preparation. The Lamarckian Genetic Algorithm (LGA) was used to explore the space of the binding site, centered on the CHX interaction site on each cathepsin molecule. Step sizes of 2 Å for translation and 15 Å for rotation were chosen, and the maximum number of energy evaluations was set at 300,000. For each run, a maximum number of 270,000 LGA operations was generated on populations of 200 individuals. Operator weights for crossover, mutation, and elitism were set at 0.80, 0.02, and 1, respectively. The orientations of ligand molecules at the binding sites were selected from the docked conformations as representative of the lower-energy clusters generated by Autodock 4.2.</p>
</sec>
</sec>
<sec id="section6-0022034511435329" sec-type="results">
<title>Results</title>
<sec id="section7-0022034511435329">
<title>Effect of CHX on the Proteolytic Activity of Dentinal Extracted Cysteine Cathepsins</title>
<p>Proteolytic activity of cysteine cathepsins in dentin extracts was detected and severely inhibited by the specific inhibitor for this class of enzymes E-64 (<xref ref-type="fig" rid="fig1-0022034511435329">Fig. 1</xref>), demonstrating the presence of cysteine cathepsins in demineralized dentin matrix. CHX inhibited the activity of dentinal proteases in a concentration-dependent manner (IC<sub>50</sub> = 0.8 mM).</p>
<fig id="fig1-0022034511435329" position="float">
<label>Figure 1.</label>
<caption><p>Inhibition of endopeptidase activities of cysteine cathepsins in dentin extracts. The activity of cysteine cathepsins in G-2 extracts, expressed in arbitrary units of fluorescence (AUF), was monitored with the fluorogenic substrates Z-FR-MCA as described in MATERIALS &amp; METHODS. The substrate hydrolysis was performed in the absence (dentin extracts column) or in the presence of different CHX digluconate concentrations (0.02-10 mM CHX columns). The enzymatic activity of dentin extracts was also determined in the presence of 5 µM E-64 concentration (E-64 column) or in the presence of 5 µM E-64 + 10 mM CHX digluconate concentration (E-64 + CHX column).</p></caption>
<graphic xlink:href="10.1177_0022034511435329-fig1.tif"/>
</fig>
</sec>
<sec id="section8-0022034511435329">
<title>Effect of CHX on Recombinant Cathepsins B, K, and L</title>
<p>As was observed in dentin extracts, the activity of recombinant cathepsins was also inhibited with increasing concentrations of CHX (<xref ref-type="fig" rid="fig2-0022034511435329">Fig. 2</xref>). At pH 5.5, cathepsin B was inhibited by CHX, with a <italic>K</italic><sub>i</sub> of 220 ± 20 µM (IC50 = 0.8 mM), and at pH 6.7, with a <italic>K</italic><sub>i</sub> of 16 ± 2 µM (<xref ref-type="fig" rid="fig2-0022034511435329">Fig. 2A</xref>). The interaction between CHX and cathepsin B, monitored by measurement of the intrinsic fluorescence of tryptophan residues, showed that CHX suppressed 32% of the intrinsic fluorescence of recombinant human cathepsin B (<xref ref-type="fig" rid="fig2-0022034511435329">Fig. 2B</xref>). CHX strongly inhibited cathepsin K, with a <italic>K</italic><sub>i</sub> of 14 ± 2 µM, and cathepsin L, with a <italic>K</italic><sub>i</sub> of 1.2 ± 0.1 µM (<xref ref-type="fig" rid="fig2-0022034511435329">Figs. 2C</xref>, <xref ref-type="fig" rid="fig2-0022034511435329">2D</xref>).</p>
<fig id="fig2-0022034511435329" position="float">
<label>Figure 2.</label>
<caption><p>Effect of CHX on Z-FR-MCA hydrolysis by human recombinant cathepsins B, K, and L upon the intrinsic fluorescence of cathepsins B. <bold>(A)</bold> The influence of CHX digluconate concentration upon cathepsin B endopeptidase activity was determined spectrofluorimetrically by measurement of the Z-FR-MCA hydrolysis at pH 5.5 (▲) or at pH 6.7 (●), as described in MATERIALS &amp; METHODS. <bold>(B)</bold> CHX-induced changes in the intrinsic fluorescence of recombinant cathepsin B. The emission spectra were obtained for 1.0 μM recombinant cathepsin B alone (●) or in the presence of 100 μM chlorhexidine (▲). The influence of chlorhexidine concentration upon cathepsin K <bold>(C)</bold> and cathepsin L <bold>(D)</bold> endopeptidase activities was also determined spectrofluorimetrically by measurement of the Z-FR-MCA hydrolysis, in 50 mM MES, pH 5.7, containing 1 mM DTT at 37ºC.</p></caption>
<graphic xlink:href="10.1177_0022034511435329-fig2.tif"/>
</fig>
</sec>
<sec id="section9-0022034511435329">
<title>Molecular Docking Analysis of CHX Interaction with Cysteine Cathepsins</title>
<p>Molecular docking of CHX was modeled with the crystal structure of cathepsins B, K, and L, assuming that the minimum energy represents the best model for a CHX binding site. <xref ref-type="fig" rid="fig3-0022034511435329">Fig. 3</xref> shows the optimal docking site for CHX in three-dimensional cysteine cathepsin structures, indicating that the amino acid residues from subsites S2 to S2′ of the cysteine cathepsins B, K, and L interact with CHX molecules (<xref ref-type="table" rid="table1-0022034511435329">Table</xref>). Results indicate that the interaction between CHX and cathepsins B, K, and L occurs similarly. (For details of the molecular docking analysis, see the Appendix.)</p>
<fig id="fig3-0022034511435329" position="float">
<label>Figure 3.</label>
<caption><p>Representation of the complex of CHX with cysteine cathepsins B, K, and L. The secondary structure elements of each enzyme are represented by cyan blue schematics (<italic>arrows</italic> for extended strands and <italic>cylinders</italic> for helices), while the carbon atoms of CHX are indicated by <italic>light green sticks</italic>. The active site residues of the cysteine cathepsins B, K, and L are labeled following the numbering of papain. <bold>(A)</bold> Docking of CHX with cathepsin B: View of the minimum energy conformation showing CHX completely engulfed in the cathepsin B active site cavity from S2 to S2′: Cys29 and His199 are the active site residues (<italic>light yellow</italic>). The amino acid residues Tyr75, Pro76, and Glu245 (<italic>red</italic>) are at the subsite S2; Gly74 (red) and Cys29 (<italic>light yellow</italic>) residues are at the subsite S1, and the His199 (<italic>light yellow</italic>) residue is at the subsite S1′ of cathepsin B. <bold>(B)</bold> Docking of CHX with cathepsin K: View of the minimum energy conformation showing CHX completely engulfed onto the cathepsin K active site cavity from S2 to S2′: Cys25, His159, and Asn175 are the active site residues (<italic>light yellow</italic>). The amino acid residues Gln19 (<italic>red</italic>) and Cys25 (<italic>light yellow</italic>) are at the subsite S1; Gly20, Gly23 (<italic>red</italic>) are at the subsite S2′ of the cathepsin K. <bold>(C)</bold> Docking of CHX with cathepsin L: View of the minimum energy conformation showing CHX engulfed onto the cathepsin L active site cavity from S2 to S2′: Cys25 and His159 are the active site residues (<italic>light yellow</italic>). The amino acid residues Ala133 and Leu157 (<italic>red</italic>) are at the subsite S2; Gln19 (<italic>red</italic>) and Cys25 (<italic>light yellow</italic>) are at the subsite S1; Gly23 (<italic>red</italic>) is at the subsite S2′ of the cathepsin L.</p></caption>
<graphic xlink:href="10.1177_0022034511435329-fig3.tif"/>
</fig>
<table-wrap id="table1-0022034511435329" position="float">
<label>Table.</label>
<caption><p>Binding distances between chx digluconate and subsites of the catalytic domain of cysteine cathepsins B, K, and L</p></caption>
<graphic alternate-form-of="table1-0022034511435329" xlink:href="10.1177_0022034511435329-table1.tif"/>
</table-wrap>
</sec>
</sec>
<sec id="section10-0022034511435329" sec-type="discussion">
<title>Discussion</title>
<p>Hydrolysis of the fluorogenic substrate Z-FR-MCA incubated with dentin extracts confirmed the assumption that the host-derived proteolytic activity of dentin is partially due to the expression of cysteine cathepsins (<xref ref-type="bibr" rid="bibr30-0022034511435329">Tersariol <italic>et al</italic>., 2010</xref>; <xref ref-type="bibr" rid="bibr24-0022034511435329">Nascimento <italic>et al</italic>., 2011</xref>) in addition to that due to MMPs. In conjunction, the 3 experiments indicated that CHX has a strong interaction with cathepsins, inhibiting the activity of these enzymes dose-dependently. These results, therefore, support the acceptance of the proposed hypothesis.</p>
<p>Recent descriptions of the expression of cysteine cathepsins in cultured odontoblasts and pulp tissues (<xref ref-type="bibr" rid="bibr30-0022034511435329">Tersariol <italic>et al</italic>., 2010</xref>) and their reported activity in sound and carious dentin (<xref ref-type="bibr" rid="bibr30-0022034511435329">Tersariol <italic>et al</italic>., 2010</xref>; <xref ref-type="bibr" rid="bibr24-0022034511435329">Nascimento <italic>et al</italic>., 2011</xref>) embody the notion that these enzymes can participate in metabolic processes involving the degradation of dentin matrix components. While cathepsins B and L were reported to cleave non-helical telopeptide extensions of collagens, cathepsin K, in the presence of chondroitin 4-sulfate, may cleave the triple-helical structure of collagens, showing true collagenolytic activity (<xref ref-type="bibr" rid="bibr18-0022034511435329">Li <italic>et al</italic>., 2004</xref>).</p>
<p>The synthetic inhibitor E-64 irreversibly inhibits several cysteine proteases (<xref ref-type="bibr" rid="bibr8-0022034511435329">Dickinson, 2002</xref>). The present results showed, for the first time, that CHX also promoted a significant inhibition of cathepsin activity, comparable with that observed with E-64.</p>
<p>CHX is characterized as a strong base with cationic properties and with a potential ability to bind to the negatively charged surface/site of target substrates (<xref ref-type="bibr" rid="bibr25-0022034511435329">Nerurkar <italic>et al</italic>., 1995</xref>). Molecular docking modeling confirmed that electrostatic binding between CHX and cathepsins is possible and easily achievable. For instance, the guanidyl group of CHX established an electrostatic interaction of 2.60 Å with the carboxylate group of Glu122 residue at subsite S1 of cathepsin B, mimicking the guanidyl group of a peptidic substrate with arginine residue at P1. Also, the carboxylate group of Glu245 at the S2 subsite of cathepsin B is well-placed at 2.88 Å from the guanidyl group of chlorhexidine, mimicking the guanidyl group of a peptidic substrate with arginine residue at P2.</p>
<p>Interactions between CHX and cathepsins varied based on enzyme structure, but they were all effective in reducing the rate of Z-FR-MCA substrate hydrolysis. Effectiveness on protease inhibition was dependent on three-dimensional interactions between CHX with the amino acid residues from the active sites of these enzymes. The molecular docking analysis of CHX showed that the subsites S2 to S2′ of cathepsins B, K, and L are occupied by the CHX molecule.</p>
<p>The inhibition of cathepsin B with CHX was pH-dependent. As previously demonstrated, at acidic pH, Asp22 and His110 residues form a salt bridge in the mature cathepsin B (<xref ref-type="bibr" rid="bibr22-0022034511435329">Musil <italic>et al</italic>., 1991</xref>) that stabilizes the occluding loop of the enzyme in its closed conformation (<xref ref-type="bibr" rid="bibr23-0022034511435329">Nägler <italic>et al</italic>., 1997</xref>), thereby hiding its active site cleft. At higher pH (neutral), there is deprotonation of His110 and destruction of the Asp22-His110 salt bridge, which displaces the occluding loop (<xref ref-type="bibr" rid="bibr28-0022034511435329">Quraishi <italic>et al</italic>., 1999</xref>) and exposes the active site cleft of the enzyme. These events could explain why the inhibition of cathepsin B by CHX was more effective at pH 6.7.</p>
<p>The interaction of CHX with Trp221 at subsite S1′ and with Trp30 at subsite S1 of the cathepsin B active site (<xref ref-type="bibr" rid="bibr22-0022034511435329">Musil <italic>et al</italic>., 1991</xref>) suppresses the intrinsic fluorescence of cathepsin B. It is important to note that cathepsin B has 7 tryptophan residues in its composition, and that CHX produced a decrease of 30% in the intrinsic fluorescence of tryptophan residues present in it. This strongly suggests that CHX can indeed interact with the active site of cathepsin B.</p>
<p>Molecular docking analysis also suggested that the participation of the hydrogen atom HAK of CHX may control the mechanism of cathepsin B inhibition. Interestingly, the hydrogen atom HAK is 2.32 Å equidistant from the catalytic Cys29 thiolate-imidazole His199 ion pairing, suggesting that HAK is an important group of the CHX directly related to the mechanism of cathepsin B inhibition.</p>
<p>Thus, the well-demonstrated effect of CHX in preserving the integrity of dentin collagen may be due not only to the inhibition of MMPs, but also to the inhibition of dentinal cysteine cathepsins. Although the inhibition of cathepsins by CHX has been observed in this work, further investigations into the involvement and importance of this class of enzymes in caries pathogenesis and hybrid layer degradation may allow for the development of more effective prevention modes for these oral disorders.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="supported-by">
<p>The authors thank the funding agencies FAPESP (2007/54618-4 and 2011/12226-8, P.I. Carrilho; and 2009/14005-9, P.I. Scaffa) and CNPq (306100/2010-0, P.I. Carrilho), Brazil.</p>
</fn>
<fn fn-type="supplementary-material">
<p>A supplemental appendix to this article is published electronically only at <ext-link ext-link-type="uri" xlink:href="http://jdr.sagepub.com/supplemental">http://jdr.sagepub.com/supplemental</ext-link>.</p>
</fn>
<fn fn-type="conflict">
<p>The author(s) declared no potential conflicts of interest with respect to the authorship and/or publication of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0022034511435329">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Barrett</surname><given-names>AJ</given-names></name>
</person-group> (<year>1980</year>). <article-title>Fluorimetric assays for cathepsin B and cathepsin H with methyl coumaryl amide substrates</article-title>. <source>Biochem J</source> <volume>187</volume>:<fpage>909</fpage>-<lpage>912</lpage>.</citation>
</ref>
<ref id="bibr2-0022034511435329">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Berman</surname><given-names>HM</given-names></name>
<name><surname>Bhat</surname><given-names>TN</given-names></name>
<name><surname>Bourne</surname><given-names>PE</given-names></name>
<name><surname>Feng</surname><given-names>Z</given-names></name>
<name><surname>Gilliland</surname><given-names>G</given-names></name>
<name><surname>Weissig</surname><given-names>H</given-names></name>
<etal/>
</person-group>. (<year>2000</year>). <article-title>The Protein Data Bank and the challenge of structural genomics</article-title>. <source>Nat Struct Biol</source> <volume>7</volume>(<issue>Suppl</issue>):<fpage>957</fpage>-<lpage>959</lpage>.</citation>
</ref>
<ref id="bibr3-0022034511435329">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bradford</surname><given-names>MM</given-names></name>
</person-group> (<year>1976</year>). <article-title>A rapid and sensitive for the quantitation of microgram quantitites of protein utilizing the principle of protein-dye binding</article-title>. <source>Anal Biochem</source> <volume>72</volume>:<fpage>248</fpage>-<lpage>254</lpage>.</citation>
</ref>
<ref id="bibr4-0022034511435329">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Breschi</surname><given-names>L</given-names></name>
<name><surname>Martin</surname><given-names>P</given-names></name>
<name><surname>Mazzoni</surname><given-names>A</given-names></name>
<name><surname>Nato</surname><given-names>F</given-names></name>
<name><surname>Carrilho</surname><given-names>M</given-names></name>
<name><surname>Tjäderhane</surname><given-names>L</given-names></name>
<etal/>
</person-group>. (<year>2010</year>). <article-title>Use of a specific MMP inhibitor (Galardin) for preservation of hybrid layer</article-title>. <source>Dent Mater</source> <volume>26</volume>:<fpage>571</fpage>-<lpage>578</lpage>.</citation>
</ref>
<ref id="bibr5-0022034511435329">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Carrilho</surname><given-names>MR</given-names></name>
<name><surname>Geraldeli</surname><given-names>S</given-names></name>
<name><surname>Tay</surname><given-names>F</given-names></name>
<name><surname>de Goes</surname><given-names>MF</given-names></name>
<name><surname>Carvalho</surname><given-names>RM</given-names></name>
<name><surname>Tjäderhane</surname><given-names>L</given-names></name>
<etal/>
</person-group>. (<year>2007</year>). <article-title><italic>In vivo</italic> preservation of the hybrid layer by chlorhexidine</article-title>. <source>J Dent Res</source> <volume>86</volume>:<fpage>529</fpage>-<lpage>533</lpage>.</citation>
</ref>
<ref id="bibr6-0022034511435329">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Carrilho</surname><given-names>MR</given-names></name>
<name><surname>Carvalho</surname><given-names>RM</given-names></name>
<name><surname>Sousa</surname><given-names>EN</given-names></name>
<name><surname>Nicolau</surname><given-names>J</given-names></name>
<name><surname>Breschi</surname><given-names>L</given-names></name>
<name><surname>Mazzoni</surname><given-names>A</given-names></name>
<etal/>
</person-group>. (<year>2010</year>). <article-title>Substantivity of chlorhexidine to human dentin</article-title>. <source>Dent Mater</source> <volume>26</volume>:<fpage>779</fpage>-<lpage>785</lpage>.</citation>
</ref>
<ref id="bibr7-0022034511435329">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chowdhury</surname><given-names>SF</given-names></name>
<name><surname>Sivaraman</surname><given-names>J</given-names></name>
<name><surname>Wang</surname><given-names>J</given-names></name>
<name><surname>Devanathan</surname><given-names>G</given-names></name>
<name><surname>Lachance</surname><given-names>P</given-names></name>
<name><surname>Qi</surname><given-names>H</given-names></name>
<etal/>
</person-group>. (<year>2002</year>). <article-title>Design of noncovalent inhibitors of human cathepsin L. From the 96-residue proregion to optimized tripeptides</article-title>. <source>J Med Chem</source> <volume>45</volume>:<fpage>5321</fpage>-<lpage>5329</lpage>.</citation>
</ref>
<ref id="bibr8-0022034511435329">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dickinson</surname><given-names>DP</given-names></name>
</person-group> (<year>2002</year>). <article-title>Cysteine peptidases of mammals: their biological roles and potential effects in the oral cavity and other tissues in health and disease</article-title>. <source>C.rit Rev Oral Biol Med</source> <volume>13</volume>:<fpage>238</fpage>-<lpage>275</lpage></citation>
</ref>
<ref id="bibr9-0022034511435329">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gendron</surname><given-names>R</given-names></name>
<name><surname>Grenier</surname><given-names>D</given-names></name>
<name><surname>Sorsa</surname><given-names>T</given-names></name>
<name><surname>Mayrand</surname><given-names>D</given-names></name>
</person-group> (<year>1999</year>). <article-title>Inhibition of the activities of matrix metalloproteinases 2, 8, and 9 by chlorhexidine</article-title>. <source>Clin Diagn Lab Immunol</source> <volume>6</volume>:<fpage>437</fpage>-<lpage>439</lpage>.</citation>
</ref>
<ref id="bibr10-0022034511435329">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gesteira</surname><given-names>TF</given-names></name>
<name><surname>Coulson-Thomas</surname><given-names>VJ</given-names></name>
<name><surname>Taunay-Rodrigues</surname><given-names>A</given-names></name>
<name><surname>Oliveira</surname><given-names>V</given-names></name>
<name><surname>Thacker</surname><given-names>BE</given-names></name>
<name><surname>Juliano</surname><given-names>MA</given-names></name>
<etal/>
</person-group>. (<year>2011</year>). <article-title>Inhibitory peptides of the sulfotransferase domain of the heparan sulfate enzyme, N-deacetylase-N-sulfotransferase-1</article-title>. <source>J Biol Chem</source> <volume>286</volume>:<fpage>5338</fpage>-<lpage>5346</lpage>.</citation>
</ref>
<ref id="bibr11-0022034511435329">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Gordon</surname><given-names>MS</given-names></name>
<name><surname>Schmidt</surname><given-names>MW</given-names></name>
</person-group> (<year>2005</year>). <article-title>Advances in electronic structure theory: GAMESS a decade later</article-title>. In: <collab>Theory and applications of computational chemistry: the first forty years</collab>. <person-group person-group-type="editor">
<name><surname>Dykstra</surname><given-names>CE</given-names></name>
<name><surname>Frenking</surname><given-names>G</given-names></name>
<name><surname>Kim</surname><given-names>K</given-names></name>
<name><surname>Scuseria</surname><given-names>G</given-names></name>
</person-group>, editors. <publisher-loc>Amsterdam</publisher-loc>: <publisher-name>Elsevier</publisher-name>, pp. <fpage>1167</fpage>-<lpage>1189</lpage>.</citation>
</ref>
<ref id="bibr12-0022034511435329">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Greenspan</surname><given-names>PD</given-names></name>
<name><surname>Clark</surname><given-names>KL</given-names></name>
<name><surname>Tommasi</surname><given-names>RA</given-names></name>
<name><surname>Cowen</surname><given-names>SD</given-names></name>
<name><surname>McQuire</surname><given-names>LW</given-names></name>
<name><surname>Farley</surname><given-names>DL</given-names></name>
<etal/>
</person-group>. (<year>2001</year>). <article-title>Identification of dipeptidyl nitriles as potent and selective inhibitors of cathepsin B through structure-based drug design</article-title>. <source>J Med Chem</source> <volume>44</volume>:<fpage>4524</fpage>-<lpage>4534</lpage>.</citation>
</ref>
<ref id="bibr13-0022034511435329">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Halgren</surname><given-names>TA</given-names></name>
</person-group> (<year>1999</year>). <article-title>MMFF VI. MMFF94s option for energy minimization studies</article-title>. <source>J Comput Chem</source> <volume>20</volume>:<fpage>720</fpage>-<lpage>729</lpage>.</citation>
</ref>
<ref id="bibr14-0022034511435329">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hebling</surname><given-names>J</given-names></name>
<name><surname>Pashley</surname><given-names>DH</given-names></name>
<name><surname>Tjäderhane</surname><given-names>L</given-names></name>
<name><surname>Tay</surname><given-names>FR</given-names></name>
</person-group> (<year>2005</year>). <article-title>Chlorhexidine arrests subclinical degradation of dentin hybrid layers</article-title> <source>in vivo. J Dent Res</source> <volume>84</volume>:<fpage>741</fpage>-<lpage>746</lpage>.</citation>
</ref>
<ref id="bibr15-0022034511435329">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname><given-names>J</given-names></name>
<name><surname>Mai</surname><given-names>S</given-names></name>
<name><surname>Carrilho</surname><given-names>MR</given-names></name>
<name><surname>Yiu</surname><given-names>CK</given-names></name>
<name><surname>Pashley</surname><given-names>DH</given-names></name>
<name><surname>Tay</surname><given-names>FR</given-names></name>
</person-group> (<year>2010</year>). <article-title>An all-in-one adhesive does not etch beyond hybrid layers</article-title>. <source>J Dent Res</source> <volume>89</volume>: <fpage>482</fpage>-<lpage>487</lpage>.</citation>
</ref>
<ref id="bibr16-0022034511435329">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lessa</surname><given-names>FC</given-names></name>
<name><surname>Nogueira</surname><given-names>I</given-names></name>
<name><surname>Vargas Fda</surname><given-names>S</given-names></name>
<name><surname>Spolidorio</surname><given-names>DM</given-names></name>
<name><surname>Hebling</surname><given-names>J</given-names></name>
<name><surname>García-Godoy</surname><given-names>F</given-names></name>
<etal/>
</person-group>. (<year>2010</year>). <article-title>Direct and transdentinal antibacterial activity of chlorhexidine</article-title>. <source>Am J Dent</source> <volume>23</volume>:<fpage>255</fpage>-<lpage>259</lpage>.</citation>
</ref>
<ref id="bibr17-0022034511435329">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lessa</surname><given-names>FC</given-names></name>
<name><surname>Nogueira</surname><given-names>I</given-names></name>
<name><surname>Huck</surname><given-names>C</given-names></name>
<name><surname>Hebling</surname><given-names>J</given-names></name>
<name><surname>Costa</surname><given-names>CA</given-names></name>
</person-group> (<year>2010</year>). <article-title>Transdentinal cytotoxic effects of different concentrations of chlorhexidine gel applied on acid-conditioned dentin substrate</article-title>. <source>J Biomed Mater Res B Appl Biomater</source> <volume>92</volume>:<fpage>40</fpage>-<lpage>47</lpage>.</citation>
</ref>
<ref id="bibr18-0022034511435329">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Li</surname><given-names>Z</given-names></name>
<name><surname>Yasuda</surname><given-names>Y</given-names></name>
<name><surname>Li</surname><given-names>W</given-names></name>
<name><surname>Bogyo</surname><given-names>M</given-names></name>
<name><surname>Katz</surname><given-names>N</given-names></name>
<name><surname>Gordon</surname><given-names>RE</given-names></name>
<etal/>
</person-group>. (<year>2004</year>). <article-title>Regulation of collagenase activities of human cathepsins by glycosaminoglycans</article-title>. <source>J Biol Chem</source> <volume>279</volume>:<fpage>5470</fpage>-<lpage>5479</lpage>.</citation>
</ref>
<ref id="bibr19-0022034511435329">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Machado</surname><given-names>MF</given-names></name>
<name><surname>Rioli</surname><given-names>V</given-names></name>
<name><surname>Dalio</surname><given-names>FM</given-names></name>
<name><surname>Castro</surname><given-names>LM</given-names></name>
<name><surname>Juliano</surname><given-names>MA</given-names></name>
<name><surname>Tersariol</surname><given-names>IL</given-names></name>
<etal/>
</person-group>. (<year>2007</year>). <article-title>The role of Tyr<sup>605</sup> and Ala<sup>607</sup> of thimet oligopeptidase and Tyr<sup>606</sup> and Gly<sup>608</sup> of neurolysin in substrate hydrolysis and inhibitor binding</article-title>. <source>Biochem J</source> <volume>404</volume>:<fpage>279</fpage>-<lpage>288</lpage>.</citation>
</ref>
<ref id="bibr20-0022034511435329">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Martin-De Las Heras</surname><given-names>S</given-names></name>
<name><surname>Valenzuela</surname><given-names>A</given-names></name>
<name><surname>Overall</surname><given-names>CM</given-names></name>
</person-group> (<year>2000</year>). <article-title>The matrix metalloproteinase gelatinase A in human dentine</article-title>. <source>Arch Oral Biol</source> <volume>45</volume>:<fpage>757</fpage>-<lpage>765</lpage>.</citation>
</ref>
<ref id="bibr21-0022034511435329">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mazzoni</surname><given-names>A</given-names></name>
<name><surname>Mannello</surname><given-names>F</given-names></name>
<name><surname>Tay</surname><given-names>FR</given-names></name>
<name><surname>Tonti</surname><given-names>GA</given-names></name>
<name><surname>Papa</surname><given-names>S</given-names></name>
<name><surname>Mazzotti</surname><given-names>G</given-names></name>
<etal/>
</person-group>. (<year>2007</year>). <article-title>Zymographic analysis and characterization of MMP-2 and -9 forms in human sound dentin</article-title>. <source>J Dent Res</source> <volume>86</volume>:<fpage>436</fpage>-<lpage>440</lpage>.</citation>
</ref>
<ref id="bibr22-0022034511435329">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Musil</surname><given-names>D</given-names></name>
<name><surname>Zucic</surname><given-names>D</given-names></name>
<name><surname>Turk</surname><given-names>D</given-names></name>
<name><surname>Engh</surname><given-names>RA</given-names></name>
<name><surname>Mayr</surname><given-names>I</given-names></name>
<name><surname>Huber</surname><given-names>R</given-names></name>
<etal/>
</person-group>. (<year>1991</year>). <article-title>The refined 2.15Å x-ray crystal structure of human liver cathepsin B: the structural basis for its specificity</article-title>. <source>EMBO J</source> <volume>10</volume>:<fpage>2321</fpage>-<lpage>2330</lpage>.</citation>
</ref>
<ref id="bibr23-0022034511435329">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nägler</surname><given-names>DK</given-names></name>
<name><surname>Storer</surname><given-names>AC</given-names></name>
<name><surname>Portaro</surname><given-names>FC</given-names></name>
<name><surname>Carmona</surname><given-names>E</given-names></name>
<name><surname>Juliano</surname><given-names>L</given-names></name>
<name><surname>Ménard</surname><given-names>R</given-names></name>
</person-group> (<year>1997</year>). <article-title>Major increase in endopeptidase activity of human cathepsin B upon removal of occluding loop contacts</article-title>. <source>Biochemistry</source> <volume>36</volume>: <fpage>12608</fpage>-<lpage>12615</lpage>.</citation>
</ref>
<ref id="bibr24-0022034511435329">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nascimento</surname><given-names>FD</given-names></name>
<name><surname>Minciotti</surname><given-names>CL</given-names></name>
<name><surname>Geraldeli</surname><given-names>S</given-names></name>
<name><surname>Carrilho</surname><given-names>MR</given-names></name>
<name><surname>Pashley</surname><given-names>DH</given-names></name>
<name><surname>Tay</surname><given-names>FR</given-names></name>
<etal/>
</person-group>. (<year>2011</year>). <article-title>Cysteine cathepsins in human carious dentin</article-title>. <source>J Dent Res</source> <volume>90</volume>:<fpage>506</fpage>-<lpage>511</lpage>.</citation>
</ref>
<ref id="bibr25-0022034511435329">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nerurkar</surname><given-names>MJ</given-names></name>
<name><surname>Zentner</surname><given-names>GM</given-names></name>
<name><surname>Rytting</surname><given-names>JH</given-names></name>
</person-group> (<year>1995</year>). <article-title>Effect of chloride in the releasing of chlorhexidine salts from methyl methacrylate: 2-hydroxyethyl methacrylate copolymer reservoir devices</article-title>. <source>J Control Release</source> <volume>33</volume>:<fpage>357</fpage>-<lpage>363</lpage>.</citation>
</ref>
<ref id="bibr26-0022034511435329">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pashley</surname><given-names>DH</given-names></name>
<name><surname>Tay</surname><given-names>FR</given-names></name>
<name><surname>Yiu</surname><given-names>C</given-names></name>
<name><surname>Hashimoto</surname><given-names>M</given-names></name>
<name><surname>Breschi</surname><given-names>L</given-names></name>
<name><surname>Carvalho</surname><given-names>RM</given-names></name>
<etal/>
</person-group>. (<year>2004</year>). <article-title>Collagen degradation by host-derived enzymes during aging</article-title>. <source>J Dent Res</source> <volume>83</volume>:<fpage>216</fpage>-<lpage>221</lpage>.</citation>
</ref>
<ref id="bibr27-0022034511435329">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pashley</surname><given-names>DH</given-names></name>
<name><surname>Tay</surname><given-names>FR</given-names></name>
<name><surname>Breschi</surname><given-names>L</given-names></name>
<name><surname>Tjäderhane</surname><given-names>L</given-names></name>
<name><surname>Carvalho</surname><given-names>RM</given-names></name>
<name><surname>Carrilho</surname><given-names>M</given-names></name>
<etal/>
</person-group>. (<year>2011</year>). <article-title>State of the art etch-and-rinse adhesives</article-title>. <source>Dent Mater</source> <volume>27</volume>: <fpage>1</fpage>-<lpage>16</lpage>.</citation>
</ref>
<ref id="bibr28-0022034511435329">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Quraishi</surname><given-names>O</given-names></name>
<name><surname>Nägler</surname><given-names>DK</given-names></name>
<name><surname>Fox</surname><given-names>T</given-names></name>
<name><surname>Sivaraman</surname><given-names>J</given-names></name>
<name><surname>Cygler</surname><given-names>M</given-names></name>
<name><surname>Mort</surname><given-names>JS</given-names></name>
<name><surname>Storer</surname><given-names>AC</given-names></name>
</person-group> (<year>1999</year>). <article-title>The occluding loop in cathepsin B defines the pH dependence of inhibition by its propeptide</article-title>. <source>Biochemistry</source> <volume>38</volume>:<fpage>5017</fpage>-<lpage>5023</lpage>.</citation>
</ref>
<ref id="bibr29-0022034511435329">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sulkala</surname><given-names>M</given-names></name>
<name><surname>Tervahartiala</surname><given-names>T</given-names></name>
<name><surname>Sorsa</surname><given-names>T</given-names></name>
<name><surname>Larmas</surname><given-names>M</given-names></name>
<name><surname>Salo</surname><given-names>T</given-names></name>
<name><surname>Tjäderhane</surname><given-names>L</given-names></name>
</person-group> (<year>2007</year>). <article-title>Matrix metalloproteinase-8 (MMP-8) is the major collagenase in human dentin</article-title>. <source>Arch Oral Biol</source> <volume>52</volume>:<fpage>121</fpage>-<lpage>127</lpage>.</citation>
</ref>
<ref id="bibr30-0022034511435329">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tersariol</surname><given-names>IL</given-names></name>
<name><surname>Geraldeli</surname><given-names>S</given-names></name>
<name><surname>Minciotti</surname><given-names>CL</given-names></name>
<name><surname>Nascimento</surname><given-names>FD</given-names></name>
<name><surname>Pääkkönen</surname><given-names>V</given-names></name>
<name><surname>Martins</surname><given-names>MT</given-names></name><etal/>
</person-group>. (<year>2010</year>). <article-title>Cysteine cathepsins in human dentin-pulp complex</article-title>. <source>J Endod</source> <volume>36</volume>:<fpage>475</fpage>-<lpage>481</lpage>.</citation>
</ref>
<ref id="bibr31-0022034511435329">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Thompson</surname><given-names>SK</given-names></name>
<name><surname>Halbert</surname><given-names>SM</given-names></name>
<name><surname>Bossard</surname><given-names>MJ</given-names></name>
<name><surname>Tomaszek</surname><given-names>TA</given-names></name>
<name><surname>Levy</surname><given-names>MA</given-names></name>
<name><surname>Zhao</surname><given-names>B</given-names></name>
<etal/>
</person-group>. (<year>1997</year>). <article-title>Design of potent and selective human cathepsin K inhibitors that span the active site</article-title>. <source>Proc Natl Acad Sci USA</source> <volume>94</volume>:<fpage>14249</fpage>-<lpage>14254</lpage>.</citation>
</ref>
<ref id="bibr32-0022034511435329">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tjäderhane</surname><given-names>L</given-names></name>
<name><surname>Larjava</surname><given-names>H</given-names></name>
<name><surname>Sorsa</surname><given-names>T</given-names></name>
<name><surname>Uitto</surname><given-names>VJ</given-names></name>
<name><surname>Larmas</surname><given-names>M</given-names></name>
<name><surname>Salo</surname><given-names>T</given-names></name>
</person-group> (<year>1998</year>). <article-title>The activation and function of host matrix metalloproteinases in dentin matrix breakdown in caries lesions</article-title>. <source>J Dent Res</source> <volume>77</volume>:<fpage>1622</fpage>-<lpage>1629</lpage>.</citation>
</ref>
<ref id="bibr33-0022034511435329">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Turk</surname><given-names>B</given-names></name>
<name><surname>Turk</surname><given-names>V</given-names></name>
<name><surname>Turk</surname><given-names>D</given-names></name>
</person-group> (<year>1997</year>). <article-title>Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors</article-title>. <source>Biol Chem</source> <volume>378</volume>: <fpage>141</fpage>-<lpage>150</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>